Phoenix

28 Posts

KFF/Washington Post Poll Looks at Parents’ Trust in Children’s Health Content on Social Media, And Unfounded Claims About Abortion Pill Safety Follow FDA Approval of Generic Version

Thttps://www.kff.org/health-information-trust/parents-trust-in-childrens-health-content-on-social-media-and-unfounded-claims-about-abortion-pill-safety/he latest release from the KFF/The Washington Post Survey of Parents, which finds that most parents report seeing children’s health content on social media, but many are unsure how to evaluate the trustworthiness of advice shared by health and wellness influencers. It also reviews misleading claims about the safety of medication abortion following the approval of a generic version of the abortion pill mifepristone, and it explores reports that federal officials are considering adding autism to the list of conditions covered by the Vaccine Injury Compensation Program.
Read More

Louisiana sues Food & Drug Administration to stop mailing of abortion medication

Louisiana Attorney General Liz Murrill filed a lawsuit this week that calls on the federal government to strike down rules that allow the distribution of abortion drugs without an in-person doctor’s visit. It’s her latest attempt to place restrictions on out-of-state shipments of mifepristone, a medication that used to terminate pregnancies but that also has other life-saving and gynecological uses.    
Read More

For this doctor, LGBTQ+ care is about the mission and the moment

In June, Dr. Maingi became chair of the AMA LGBTQ+ Section—the newest section at the AMA, created just last year—which addresses issues of interest to LGBTQ+ medical students, residents and fellows, physicians, patients and their allies. “We’re living in a very diverse world, with much more acceptance and acknowledgement that health care is for everybody—that there are differences that are unexplored, and we can't pretend everybody has the same set of needs,” said Dr. Maingi, who is a lesbian. 
Read More

Decreased Hormone-Free Intervals and Amenorrhea With Low-Dose Estrogen Combined Hormonal Contraceptives

Panelists discuss how shortened hormone-free intervals (24-4 and 24-2-2 regimens) prevent ovarian reactivation and endometrial proliferation that caused breakthrough bleeding with traditional 21/7 formulations, while addressing how amenorrhea can be viewed as either a desired therapeutic outcome or concerning adverse effect depending on patient preferences.
Read More

Week In Review

Illinois  Governor  JB  Pritzker  signed  the  Wellness  and  Oversight  for  Psychological  Resources  Act  (WOPR),  which  limits  the  use  of  artificial  intelligence  (AI)  in  therapy  and  psychotherapy  services.  WOPR  prohibits  using  AI  in  the  state  for  therapeutic  decision-making,  but  allows  licensed  behavioral  health  professionals  to  use  AI  for  administrative  and  support  tasks.  WOPR  aims  to  protect  patients  from  “unregulated  and  unqualified”  AI  products,  especially  amid  concerns  over  the  use  of  AI  chatbots  in  youth  mental  health  services.  It  also  seeks  to  preserve  the  jobs  of  thousands  of  behavioral  health  providers  in  Illinois.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.